Online Traffic Analysis of Direct-to-Consumer Websites for Hair Loss Treatment and Characterization of Finasteride Patients on a Platform in Germany: A Potential Paradigm Shift in the Treatment of Androgenetic Alopecia

    April 2023 in “ Clinical, Cosmetic and Investigational Dermatology ”
    F Abeck, I. Hansen, I Wiesenhütter, Florian Schröder, Julian Kött, Stefan W Schneider, Johannes von Büren
    TLDR More people are using online platforms for hair loss treatment due to convenience and privacy.
    The study analyzed online traffic and patient characteristics for direct-to-consumer websites offering finasteride treatment for androgenetic alopecia (AA) from Q1 2018 to Q1 2022, revealing a significant increase in visitors, particularly to Keeps, Shapiro MD, and Myspring. Analysis of 2,904 male patients from a German platform showed a mean age of 32.7 years, with 53.9% residing in rural areas, and most discovering the platform through TV and Google ads. The study suggests a potential paradigm shift towards digital care for AA, driven by patient preference for convenience and privacy, while also highlighting the benefits for minorities and those with lower incomes, despite concerns about overdiagnosis and patient safety.
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results

    Related Community Posts Join

    6 / 1000+ results

      community How do we only have two treatments to combat hair loss at this point in time?

      in Chat  211 upvotes 1 year ago
      The post discusses frustration over the limited and not always effective treatments for hair loss, mainly Minoxidil and Finasteride. The conversation includes mentions of potential new treatments like GT20029, HMI-115, CosmeRNA, KX-826, and microneedling, but also highlights the challenges of funding and prioritizing research in this area.

      community Male pattern baldness, and mental health

      in Finasteride/Dutasteride  325 upvotes 10 months ago
      A 48-year-old man has been using minoxidil for 15 years and considered finasteride but stopped due to potential side effects. He is concerned about his mental health and the impact of hair loss on self-image, and he encourages support among men experiencing hair loss.

      community He used Dutasteride for 20 years. Interview

      in Treatment  108 upvotes 1 month ago
      Dutasteride has been used for 20 years with some hair thickness improvement but no dramatic regrowth. The user also experimented with minoxidil, tretinoin, and peptides like BPC 157 for potential benefits in hair density and quality.

      community Upcoming Setipiprant clinical trials hint at systemic daily dosage

       21 upvotes 8 years ago
      The conversation discusses the safety, tolerability, and efficacy of oral Setipiprant tablets for treating androgenetic alopecia compared to finasteride. It mentions the high cost of Setipiprant on the black market and the trial's end date in September 2017.

    Similar Research

    5 / 1000+ results